Bioactive Oxadiazoles 3.0
Antonio Palumbo Piccionello

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsClick Chemistry and Applications · Synthesis and biological activity · Synthesis and Reactivity of Heterocycles
Heterocycles are fundamental moieties for the construction of new compounds with perspective applications ranging from drugs to materials [1,2,3,4].
In this wide panorama we focused our attention to the sub-class of Oxadiazoles. Oxadiazoles are electron-poor five-membered aromatic heterocycles that contain one oxygen and two nitrogen atoms. The oxadiazoles, namely 1,2,3-, 1,2,4-, 1,2,5-, and 1,3,4-regioisomers, together with N-oxides, benzo-fused, and non-aromatic derivatives, present a wide application range from material science to explosives and bioactive compounds [5,6,7,8]. In the latter field, there are many possibilities, and oxadiazoles have been revealed to be active as antitumoral agents [5,9], neuroprotective compounds [10], antimicrobials [8,11], among others.
Some bioactive oxadiazoles have reached the market or are in the advanced clinical trials stage, such as oxolamine, ataluren, raltegravir, capeserod, azilsartan, furazabol, sydnophen, zibotentan, opicabone, etc. Moreover, the oxadiazole skeleton is also present in some natural compounds, such as phidianidine and quisqualic acid, providing new inspiration for the synthesis of bio-inspired drugs. Another important issue is the use of oxadiazoles in medicinal chemistry as amide and ester isosters and as peptido-mimetics, offering a well-established tool for drug design. All of these aspects have increased interest in these heterocycles, increasing the impact of oxadiazoles in the field of bioactive compounds. This Special Issue is the continuation of our previous Special Issues “Bioactive Oxadiazoles” [12] and “Bioactive Oxadiazoles 2.0” [13] and is intended to offer a wide panorama of the potential applications of these compounds toward all diseases.
The research fields explored in this Special Issue include the discovery of new compounds with various biological activities such as: antibacterial 1,2,4-oxadiazole derivatives [14], antiplasmodial 1,2,5-oxadiazoles [15], 1,2,4-oxadiazole derivatives as nematicides [16] and 1,3,4-oxadiazoles with anticancer activity [17]. Moreover, the synthetic accessibility of bioactive 1,2,4-oxadiazoles at room temperature, was reviewed [18]. These researches are just some examples of the fascinating and expanding field of oxadiazoles’ chemistry, that represent an emerging field with growing potential.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Kerru N. Gummidi L. Maddila S. Gangu K.K. Jonnalagadda S.B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications Molecules 202025190910.3390/molecules 2508190932326131 PMC 7221918 · doi ↗ · pubmed ↗
- 2Rizzo C. Amata S. Pibiri I. Pace A. Buscemi S. Palumbo Piccionello A. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022 Int. J. Mol. Sci.202324772810.3390/ijms 2409772837175436 PMC 10178595 · doi ↗ · pubmed ↗
- 3Hirai M. Tanaka N. Sakai M. Yamaguchi S. Structurally constrained boron-, nitrogen-, silicon-, and phosphorus-centered polycyclic π-conjugated systems Chem. Rev.20191198291833110.1021/acs.chemrev.8b 0063730860363 · doi ↗ · pubmed ↗
- 4Rizzo C. Pace A. Pibiri I. Buscemi S. Palumbo Piccionello A. From Conventional to Sustainable Catalytic Approaches for Heterocycles Synthesis Chem Sus Chem 202417 e 20230160410.1002/cssc.20230160438140917 · doi ↗ · pubmed ↗
- 5Benassi A. Doria F. Pirota V. Groundbreaking Anticancer Activity of Highly Diversified Oxadiazole Scaffolds Int. J. Mol. Sci.202021869210.3390/ijms 2122869233217987 PMC 7698752 · doi ↗ · pubmed ↗
- 6Salassa G. Terenzi A. Metal Complexes of Oxadiazole Ligands: An Overview Int. J. Mol. Sci.201920348310.3390/ijms 2014348331315181 PMC 6678488 · doi ↗ · pubmed ↗
- 7Campofelice A. Lentini L. Di Leonardo A. Melfi R. Tutone M. Pace A. Pibiri I. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRI Ds)Int. J. Mol. Sci.201920332910.3390/ijms 2013332931284579 PMC 6651739 · doi ↗ · pubmed ↗
- 8Glomb T. Świątek P. Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives Int. J. Mol. Sci.202122697910.3390/ijms 2213697934209520 PMC 8268636 · doi ↗ · pubmed ↗
